Fisetin Suppresses Atherosclerosis by Inhibiting Ferroptosis-Related Oxidative Stress in Apolipoprotein E Knockout Mice
Pharmacology · 2024 · 109 (3) · 169-179
DOI: 10.1159/000538535 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacology, online erschienen am 18.04.2024. Verfasst von Xiufang Jiang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Affairs, The First Hospital of Hebei Medical University, Shijiazhuang, China. Hauptthemen laut MEDLINE: Flavonols, Atherosclerosis, Oxidative Stress, Ferroptosis. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
Introduction
Fisetin has been demonstrated to inhibit the occurrence of atherosclerosis; however, the mechanism of fisetin suppressing atherosclerosis remains elusive.
Methods
The function of fisetin in the inhibition of atherosclerosis was evaluated by hematoxylin and eosin and Oil Red O staining in ApoE−/− mice. Molecular biomarkers of atherosclerosis progression were detected by Western blot and qPCR. Moreover, the inhibition of atherosclerosis on oxidative stress and ferroptosis was evaluated by immunofluorescence staining, qPCR, and Western blot assays.
Results
The obtained results showed that serum lipid was attenuated and consequentially the formation of atherosclerosis was also suppressed by fisetin in ApoE−/− mice. Exploration of the mechanism revealed that molecular biomarkers of atherosclerosis were decreased under fisetin treatment. The level of reactive oxygen species and malondialdehyde declined, while the activity of superoxide dismutases and glutathione peroxidase was increased under the fisetin treatment. Additionally, the suppressor of ferroptosis, glutathione peroxidase 4 proteins, was elevated. The ferritin was decreased in the aortic tissues treated with fisetin.
Conclusions
In summary, fisetin attenuated the formation of atherosclerosis through the inhibition of oxidative stress and ferroptosis in the aortic tissues of ApoE−/− mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Affairs, The First Hospital of Hebei Medical University, Shijiazhuang, China.
- Hebei Key Laboratory of Cardiac Injury Repair Mechanism Study, Shijiazhuang, China.
- Department of Pediatrics, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
- Hebei Key Laboratory of Heart and Metabolism, Shijiazhuang, China.
- Department of Cardiology, The First Hospital of Hebei Medical University, Shijiazhuang, China.
- Hebei Engineering Research Center of Intelligent Medical Clinical Application, Shijiazhuang, China.
Zitieren
APA
Jiang, X., Lei, Y., Yin, Y., Ma, F., Zheng, M., & Liu, G. (2024). Fisetin Suppresses Atherosclerosis by Inhibiting Ferroptosis-Related Oxidative Stress in Apolipoprotein E Knockout Mice. Pharmacology, 109(3), 169-179. https://doi.org/10.1159/000538535
Vancouver
Jiang X, Lei Y, Yin Y, Ma F, Zheng M, Liu G. Fisetin Suppresses Atherosclerosis by Inhibiting Ferroptosis-Related Oxidative Stress in Apolipoprotein E Knockout Mice. Pharmacology. 2024;109(3):169-179. doi:10.1159/000538535
BibTeX
@article{Jiang2024,
author = {Jiang, Xiufang and Lei, Yanling and Yin, Yajuan and Ma, Fangfang and Zheng, Mingqi and Liu, Gang},
title = {Fisetin Suppresses Atherosclerosis by Inhibiting Ferroptosis-Related Oxidative Stress in Apolipoprotein E Knockout Mice},
journal = {Pharmacology},
year = {2024},
volume = {109},
number = {3},
pages = {169--179},
doi = {10.1159/000538535}
}
EUVIMED